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Abstract: This study was designed to determine carnitine concentrations in newborn calves with suspected septicaemia, healthy calves, and
colostrum samples as well as to detect alterations in blood carnitine concentrations after colostrum intake. Carnitine concentrations were
detected in both neonatal calves with suspected septicaemia (n = 195) and healthy calves (n =10) as well as in colostrum/milk samples from
their dams (n = 20). The mean carnitine concentration on the 2nd day after colostrum intake (32.61 µmol/L) was significantly higher than
that measured before colostrum intake (17.61 µmol/L) (P < 0.05). The striking result was significantly lower mean carnitine concentration
detected in calves with suspected septicaemia (17.11 µmol/L), compared to healthy calves (24.92 µmol/L) (P < 0.001). Apart from a sudden
increase on day 7, no significant alteration was observed in colostrum/milk carnitine concentrations throughout the postpartum period. The
results indicated that colostrum contained carnitine, which passed into the bloodstream of the calf by passive colostral transfer, and that a
dramatic reduction in blood carnitine concentrations of calves with suspected septicaemia existed. The results might be of help in dealing with
septicaemia suspected neonatal calves through both measurement of blood carnitine and, in response, to supplement such cases with carnitine.
Key words: Carnitine, septicaemia, neonatal calves, passive immunity, colostrum/milk

1. Introduction
Septicaemia, defined as the existence of microorganism
or microbial toxins in the bloodstream due to a systemic
disease [1], is closely linked to systemic inflammatory
response syndrome (SIRS) triggered by the activation
of inflammatory mediators [2], which might eventually
lead to multiple organ dysfunction and high mortality if
left untreated [3]. Septicaemia is manifested by several
clinical findings, including abnormal fever, bradycardia or
tachycardia, tachypnoea, and abnormal leukocyte count.
Although extensively studied in human, there exists no
widely eccepted model for the diagnosis and prognosis of
septicaemia or sepsis [4].
In large animal medicine, a few study involving
septicaemia exist and the majority of these studies lacked
bacterial diagnoses [5] and had diagnosis mostly relied
on clinical examination [6,7] and postmortem findings in
euthanized or dead calves suspected of septicaemia [1,8].

In a recent study [9], confirmation of sepsis was based on
SIRS, clinical signs, and bacterial culture results performed
after death of cases in which a local infection such as
omphalitis or swollen joints, was noted. Furthermore,
only a few study has used clinical and laboratory models,
and there is no internationally accepted definition of
septicaemia [1,5,7,10]. In veterinary medicine, a complete
blood cell count and scores combined with clinical findings
aid in the diagnosis of sepsis/septicaemia. Haematological
analyses increase diagnostic accuracy [7] as related
haematological abnormalities are known to vary with the
severity of the septicaemia. Commonly observed findings
include an increased number of immature cell forms
(band, myelocyte, metamyelocyte), toxic neutrophil and
abnormal neutrophil counts (neutrophilia or neutropenia)
[6,11,12].
In the neonatal period, particularly during the first
week of life, high morbidity and mortality rates are
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observed in calves [13,14]. The risk of mortality associated
with infection range between 15-30% but poor herd
management practices may increase the mortality rate up
to 50%. Concurrent inadequate passive colostral immunity
(PCI) may increase the prevalence of neonatal septicaemia
up to 30%, and may decline the survival rate to 12% in
calves [7,15]. The only defence mechanism of newborn
calves against neonatal septicaemia is PCI. The level of
PCI is determined by the direct measurement of the blood
IgG concentration. Studies have mainly focused on the
role of IgG in preventing infections of neonates [14,16].
However, in practice some newborns with adequate
transfer of colostral IgG acquire infection and some with
insufficient transfer of IgG resist infection. This fact adds
credential to the idea that significant components other
than IgG in colostrum may ptotect neonates against
microbial disease. Some of these companents may include
cytokine, acute phase protein, and lactoferrin [17,18]. One
of these protective companents may also be carnitine. The
detection of significant alterations in any parameter after
colostrum intake suggests a possible association of this
parameter with PCI [19].
Septicaemia/sepsis progresses rapidly in newborn
calves, unfurtunately usually results in death. In such cases,
it is essential to initiate antimicrobial and supplementary
treatment as early as possible. Because, each hour of delay
increases the mortality rate by 6% [1]. In this respect,
recent studies have focused on the use of novel biomarkers
for the early diagnosis of septicaemia and the development
of an optimum treatment strategy. One of these novel
biomarkers could be carnitine. While L-carnitine
concentrations have been investigated in septic human
neonates [20], no study has been performed in neonatal
calves with regard to septicaemia.
L-carnitine
(gamma-triethylamine-betahydroxybutyric acid, vitamin BT) is synthesized from
amino acids in the liver, brain and kidneys, and has a
major role in the generation of energy from fatty acids in
the mitochondria [21–23]. In blood, 80% of carnitine is
found in free form and the remaining is in ester form and
is delivered to tissues by blood [24]. Carnitine serves two
main functions: i) a catalytical function in the transport of
fatty acids into the mitochondria, ii) a metabolic function by
buffering excessive esters. Carnitine is also reported to affect
the immune system by increasing the cellular antioxidant
capacity, inducing phagocytic activity in granulocytes,
activating monocytes/macrophages, increasing antibody
concentrations (i.e. IgA and IgG) through the stimulation
of T and B lymphocytes, accelerating phagocytosis,
increasing the production of cytokines such as TNF-α, IL2ß and IL-6, and increasing or regulating the acute phase
reaction [25–28]. The determination of free carnitine and
carnitine ester in the blood provides insight on carnitine
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metabolism, which aids in the prevention of metabolic
diseases and the development of treatment protocols for
clinical practice [23,29]. Septicaemia and microbial agents
can lead to impaired lipid metabolism and hepatic energy
generation due to fatty acid oxidation [20,27]. This, in
result, may cause a risk of carnitine deficiency in critically
ill newborn calves.
Available information suggests that carnitine may
provide a protective effect against neonatal diseases in
calves, yet to date, this topic has not been studied in the
veterinary field. In view of the paucity of information, this
study was aimed at the determination of carnitine levels
in newborn calves with suspected neonatal septicaemia,
healthy calves, and colostrum samples. Furthermore, this
study targeted, for the first time, the detection of alterations
in neonatal blood carnitine concentrations after colostrum
intake. Thereby, the significance of carnitine in terms of
the pathogenesis and prognosis of neonatal calf diseases
was ascertained.
2. Material and methods
Suspected septicaemia group: The study included 195
septicaemia suspected neonatal calves admitted or referred
to the Teaching Hospital of Faculty of Veterinary Medicine,
Kafkas University by owners or veterinary practitioners
in the Kars region. A modified version of the previously
described model was used for the selection of cases [57,30]. The inclusion criteria for suspected septicaemia
were: (1) the presence of local or generalized infection
(enteritis, pneumonia, swollen joints or omphalitis etc.),
(2) existence of at least two findings related to SIRS, and
(3) manifestation of at least two clinical signs related to
septicaemia.
SIRS related inclusison criteria comprised of abnormal
rectal temperature [hypothermia or hyperthermia,
(reference interval 36-39.5 °C), heart rate (tachycardia: >
160 beats/min or bradycardia: < 90 beats/min), respiratory
rate (tachypnoea: > 45 breaths/min), and leukocyte count,
i.e. leukopenia or leukocytosis (reference intervall, 4–12
109 /L) as reported previously [1,5].
Septicaemia related clinical signs used for inclusion
were poor or absence of suckling reflex, calf posture
or attitude (lethargy, fatigue, lateral recumbency),
observation of any of the following: full congestion, marked
hyperaemia, cyanosis, anaemia, petechiae, haemorrhage
or hypopyon of mucosal or scleral vessels/membranes,
severe dehydration, prolonged capillary refill time or low
urine output, and weakness or depression [1,9,30,31].
Calves were grouped according to age on admission as 1,
2, 3–4, 5–7, 8–14 and 15–28 days old.
Treatment protocol: These calves did not receive any
treatment before admission to the hospital. Ill calves
were subjected to a standardized treatment protocol
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according to presenting clinical problem, which included
intravenous fluid therapy (performed according to the
patients’ requirements), administration of appropriate
antimicrobials, nonsteroidal antiinflammatory drugs, and
supportive care on admission [31]. Clinical examinations,
selection of the cases, and treatment were all performed by
the first author.
Healthy group: This group involved ten calves, raised
on the dairy farm of the Faculty of Veterinary Medicine,
Kafkas University, and were confirmed to be healthy based
on laboratory and clinical examinations. A total of twenty
healthy cows, ten of which were dam of the healthy group,
from the same farm was also used for colostrum and milk
sampling.
Haematological evaluation: Blood samples were
collected into 2-mL EDTA coated tubes and analysed
in an automated haematology cell counter (Hemocell
Counter MS4e, Melet Schloesing Laborators, France)
within 5 min of blood collection. Following leukocyte
count, three blood smears were prepared for each calf
from the fresh blood samples collected into EDTA coated
tubes for leukocyte analysis. The smears were air-dried,
methanol fixed, Giemsa stained and examined under a
light microscope (Nikon Eclipse E600, Japan) at ×100
magnification. Thereby, degenerative changes in WBCs
were assessed semiquantitatively. The percentage (%) of
metamyelocytes or myelocytes in the calves with suspected
septicaemia was evaluated as follows: ≤ 2% (normal
or slight elevation) and > 2% (mild/marked increase).
The band neutrophil percentages were categorized as:
≤ 2%, 3%–10%, 11%–20%, and > 20%. Toxic changes in
neutrophils were determined based on the percentages of
cytoplasmic basophilia, toxic granules, Dohle bodies, and
dark blue grey foamy cytoplasm. The percentage (%) of
toxic neutrophils were categorized as: ≤ 1% and 2%.
Collection of blood samples: Blood samples were
collected from healthy and sick calves before treatment
from all calves by jugular vein puncture into 5-mL clot
activated tubes and EDTA coated tubes (BD Vacutainer,
BD, Franklin Lakes, NJ, USA). Serum and plasma were
harvested by centrifugation at 4000 rpm and 2000 rpm,
respectively, for 10 min and stored at −20 °C until analyses.
In order to monitor carnitine and IgG concentrations, 10
healthy neonatal calves were also blood sampled before
(precolostral time = 0 h) and after colostrum intake (on days
1, 2, 3–4, 5–7, 8–14, and 15–28) as planned beforehand.
The healthy calves were bottle-fed with colostrum in an
amount equivalent to 10% of their body weight.
Serum IgG and glucose analysis: Serum IgG
concentrations were measured using a commercial ELISA
kit (Bio-X Elisa Kit for Bovine Immunoglobulin AssaysBIO K 165, Bio-X Diagnostics, Rochefort, Belgium). Serum
glucose levels were measured spectrophotometrically
using a commercial kit (Tanı Medical, Ankara, Turkey,

TML) on an autoanalyser (Roche Cobas C501, Roche
Diagnostic, Germany).
Plasma carnitine measurement: The method described
by Galan et al. [32] for the measurement of plasma
L-carnitine concentrations is based on a reaction catalyzed
by carnitine acetyltransferase (CAT) (EC.2.3.1.7) acting
on L-carnitine. The acyl group of acyl-CoA is transferred
to carnitine by CAT. Coenzyme A reacts with 5,5-dithiobis
(2-nitrobenzoic acid) to form the phenolate ion. The
formation of phenolate is proportional to the amount of
L-carnitine and measured by a spectrophotometer at 405
nm. This method was later modified by Prieto et al. [33].
The methods described by Galan et al. [32] and Prieto et
al. [33] were used to measure the plasma concentrations
of free carnitine in calves with suspected septicaemia and
healthy calves.
Preparation of colostrum samples: Colostrum
samples were taken from healthy cows (n = 20) into 10
mL glass tubes (Venoject, Code: VT-100SU, Terumo)
within 0–4 h of parturition. Colostrum with IgG > 50 g/L
was considered as good quality. Of the 20 cows, 10 were
the dam of those healthy calves used as control. Milk
samples were taken from the same cows on postpartum
days 1, 3, and 7. Milk and colostrum samples in tubes
were centrifuged upside down at 4000 rpm for 30 min to
remove fat and sediments. The samples were stored in 1.5
mL eppendorf or microcentrifuge tubes at −20 ºC until
analysis. Prior to analysis, the colostrum and milk samples
were diluted in physiological saline (10-fold for milk and
100-fold for colostrum analysis) and filtered twice through
a nylon-66 syringe filter (0.45-µl MILLIPORE, USA) to
obtain transparent samples [18,34]. Transparent samples
were used for the analyses.
Colostral/Milk IgG and free carnitine analyses:
Colostrum and milk IgG concentrations were tested using
the same kit as serum IgG measurements. Colostrum
and milk carnitine concentrations were measured
spectrophotometrically as described by Prieto et al. [33]
and Galan et al. [32]. Carnitine and IgG concentrations
were expressed as µmol/L and mg/dL, respectively.
Statistical analysis: The statistical comparison of the
data was performed using the SPSS software program
(SPSS 18.0, Chicago, IL, USA). The distribution of the
data was tested for conformity to a normal distribution
by the Shapiro–Wilk test. Afterwards, the comparison of
two groups was performed with the independent sample
T-test. One-way ANOVA and Tukey’s HSD test were used
to compare multiple groups. The statistical differences
between the different days were determined with repeatedmeasures ANOVA and the Bonferroni method. Pearson
correlation was used to determine correlation between
carnitine and IgG concentrations. Data are expressed as
mean ± SE, and the statistical significance was set at P <
0.05.
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3. Results
A total of 195 cases were admitted or referred to the hospital.
Number of cases determined on days 1, 2, 3–4, 5–7, 8–14,
and 15–28 were 26 (13.3%), 40 (20.6%), 47 (24.1%), 36
(18.5%), 17 (8.7%), and 29 (14.9%), respecticely. The
majority of cases (76.4%, 149/195) were in their first week
of life. The case fatality rate was 31% (60/195) and 61.7%
(37/60) of the deaths occurred within their first week of
life. Of these cases, 56.9% (111/195) were diagnosed with
diarrhoe, 16.4% (32/195) with pneumonia, 6.1% (12/195)
with omphalitis, 6.1% (12/195) with pneumonia-enteritis,
4.1% (8/195) with omphalitis-enteritis, 3.6% (12/195) with
pneumonia-omphalitis and 6.6% (13/195) with unkonw
reason (Table 1). Case fatality rate was 26.1% (29/111) for
diarrhoea, 40.6% (13/32) for pneumonia, 16.7% (2/12) for
omphalitis, 50% (6/12) for pneumonia-enteritis, 37.5%
(3/8) for omphalitis-enteritis, 14.3% (1/7) for pneumoniaomphalitis and 46.2% (6/13) for unknown reason (Table
1).
The difference between serum IgG concentrations
determined before colostrum intake and after colostrum
intake was statistically significant (P < 0.001) (Table 2).
Following colostrum intake, a significant increase was
observed in the plasma carnitine concentrations on day 2
(31.56 ± 0.79 µmol/L) compared to day 0 (17.04 ± 0.24
µmol/L). However, it did not differ in samples collected on
the other days or periods (Table 2).
A negative correlation was determined between IgG
and carnitine concentrations measured before colostrum
intake (day 0) and after colostrum intake (day 1, day 2,
days, 3–4, days 5–7, days 8–14, days 15–28), but this
correlation was not statistically significant (Table 3).
Comparison of the carnitine concentrations measured
in the ill and healthy calves: The plasma carnitine
concentrations of ill calves admitted on day 2, between days
3–4 and between days 8–14, were found to be significantly
lower than those of healthy calves (P < 0.001, P < 0.01 and
P < 0.05, respectively). Similarly, carnitine concentrations
of sick calves of day 1 were lower than the concentrations
measured in healthy calves. However, this difference was
statistically insignificant (P = 0.059). On the other days
and during the sampling, the carnitine cocncentrations
of the ill and healthy animals were observed to be similar
(Table 4).
Failure of passive colostral transfer (IgG < 800 mg/
dL) was determined to have developed in 57.89% of the
calves with suspected septicaemia. Mean serum glucose
level of the ill calves (71 ± 2.1 mg/dL) was significantly
(P < 0.001) lower than that of healthy calves (105 ± 2.4
mg/dL). Similarly, plasma carnitine concentrations of ill
calves (17.12 ± 0.10 µmol/L) were significantly lower than
those of healthy calves (24.94 ± 0.26 µmol/L) (P < 0.001,
Figure 1). In addition, the plasma carnitine concentrations
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Table 1. The frequency of clinical diagnosis and case fatality rate
in neonatal calves.
Clinical diagnosis

Frequency (%)

Case fatality (%)

Diarrhoe

56.9 (111/195)

26.1 (29/111)

Pneumonia

16.4 (32/195)

40.6 (13/32)

Omphalitis

6.1 (12/195)

16.7 (2/12)

Pneumonia-enteritis

6.1 (12/195)

50 (6/12)

Omphalitis-enteritis

4.1 (8/195)

37.5 (3/8)

Pneumonia-omphalitis

3.6 (7/195)

14.3 (1/7)

Unknown

6.6 (13/195)

46.2 (6/13)

of calves died (16.68 ± 0.14 µmol/L) and recovered (16.02
± 0.08 µmol/L) were determined to be significantly lower
than that of healthy calves (24.12 ± 0.24 µmol/L) (P <
0.001, Figure 1).
The assessment of the degenerative changes in the
leukocytes (WBC) showed that carnitine concentration
was 16.86 ± 0.09 µmol/L in the group with a peripheral
blood myelocyte/metamylocyte rate of ≤ 2%, and was
14.64 ± 0.12 µmol/L in those of > 2%. These two groups
were found to significantly differ in terms of carnitine
concentrations (P = 0.034). The carnitine concentrations
determined for different percentages of the groups of calves
with band neutrophils detected in the peripheral blood [ ≤
2%, 3%–10%, 11%–20% and > 20%, respectively] did not
statistically differ (P > 0.05). The carnitine concentrations
in calves with a toxic neutrophil incidence of ≤ 1% and of
≥ 2% were 16.8 ± 0.09 µmol/L and 14.46 ± 0.16 µmol/L,
respectively. These two values were significantly different
(P = 0.049) (Table 5).
Colostrum and milk analyses of carnitine: Carnitine
concentrations measured in the first colostrum (14.48 ±
0.56 µmol/L) and in the samples collected on postpartum
day 1 (14.08 ± 1.11 µmol/L) and day 3 (13.42 ± 1.04
µmol/L) (transition to milk period) were found to be
significantly (P < 0.001) lower than that measured in milk,
on postpartum day 7 (20.85 ± 3.12 µmol/L) (P < 0.001)
(Figure 2).
4. Discussion
To the best of our knowledge, this is the first investigation
on the monitorization of blood carnitine concentrations
after colostrum intake during the neonatal period in
healthy calves and the alterations and prognosis of
blood carnitine concentrations in calves with suspected
septicaemia.
The present study also disclosed critical importance of
the first week of neonatal period as approximately 76% of
calves developed diseases and 62% of them died in the first
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Table 2. Plasma carnitine (µmol/L) and serum IgG (mg/dL) concentrations (Mean±SE) in healthy calves during the neonatal
period (n = 10).
Days
0*

1

2

3–4

5–7

8–14

15–28

Carnitine

17.04 ± 0.2

23.22 ± 0.03

IgG

17 ± 2.2

1797 ± 193**

31.56 ± 0.77

26.76 ± 0.85

21.24 ± 0.51

19.5 ± 0.48

23.22 ± 0.61

1953 ± 307**

1709 ± 230**

1236 ± 88**

1216 ± 51**

1094 ± 87**

*

day 0*= Precolostral time, significantly different from day 0 (*P < 0.05, **P < 0.001).
Table 3. Correlations between carnitine and IgG concentrations in healthy neonatal calves.
Days
0

1

2

3-4

5-7

8-14

15-28

Pearson correlation

–0.067

0.083

–0.477

–0.464

–0.060

–0.343

–0.73

Significance (2-tailed)

0.863

0.821

0.163

0.149

0.888

0.333

0.841

Table 4. Plasma activity of carnitine (µmol/L) concentrations (Mean ± SE) in healthy and ill calves during the neonatal period.
Carnitine Neonatal days
N

1

N 2

N

3–4

10 26.76±0.85

N

5–7

Healthy

10 23.22 ± 0.03 10 31.56 ± 0.07

İll

27 16.56 ± 0.25 40 14.82 ± 0.14*** 45 16.38 ± 0.22** 37 20.4 ± 0.19

N

8–14

10 21.24 ± 0.51 10 19.5 ± 0.48

N

15–28

N

10 23.22 ± 0.61 60

17 15.54 ± 0.34* 29 15 ± 0.17

195

Total
24.12 ± 2.72
16.56 ±0
.10***

Significantly different between the groups *=P < 0.05, **=P < 0.01, ***=P < 0.001.

Figure 1. Carnitine concentrations according to the health status of the calves. ***
P < 0.001.

week of life. This finding once again implies the paramount
importance of the first week in the life of neonatal calves
[19, 35, 36].
Blood carnitine levels measured before and after
colostrum intake in this study suggested that colostrum

contains a high concentration of carnitine and carnitine
was readily absorbed from the intestines; however, we had
no confirmation that carnitine could be used as a marker
of passive immunity as it required demonstrating the
distribution of carnitine levels in tissue fluids, intestinal
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Table 5. Changes in carnitine concentrations according to degenerative leukocytes classification.
Leukocyte analysis (%)
Band neutrophisl
Myelocyte/metamelocytes
Toxic neutrophils
*

Carnitine concentrations (µmol/L)
n

≤%2

n

%3-10

n

%11-20

38

15.12 ± 0.17

36

18.84 ± 0.29

45

16.86 ± 0.17 49

n

≤%2

NA

NA

n

>2%

121 16.86 ± 0.09

45

14.64 ± 0.12

n

≤1%

n

≥2%

117 16.8 ± 0.09

31

14.46 ± 0.17

n

%>20

P value

15.06 ± 0.13

NA NA
0.034*

NA

NA

NA NA
0.049*

Statistically different, NA not applicable.

Figure 2. Carnitine concentrations in colostrum and transition milk
(Postpartum days 1, 3, 7) a,b: P < 0.001.

receptors mediating the absorption of carnitine, and
absorption kinetics of carnitine after colostrum intake
[37], which was not studied. Nonetheless, available
information indicates that carnitine, which has an
important role in neonatal immunity, is synthesized at
very low levels in newborn animals, and thus, is required
to be supplied from colostrum or milk in the form of
carnitine ester, which is converted to free carnitine in
mitocondria [21, 38, 39]. This may explain the increases
detected in blood carnitine concentrations after colostrum
intake in our study as a significant rise was noted in
blood carnitine concentrations of the healthy newborn
calves after the second day of birth that might indicate
higher level of maternal carnitine ester in colostrum. In
spite of an increase in carnitine concentrations of milk
on day 7, a parallel rise was not noted in blood carnitine
concentrations. This divergence might be attributed to
substantial reduction in intestinal absorption of colostral
component, including carnitine, after 48 h of life [16, 18]
or to carnitine metabolism, where milk content might
not influence the blood concentration as it is mainly
synthesized from amino acides in liver, kidney, and brain
as calves age [21, 23]. However, it should be stated that
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carnitine absorbtion dynamics reqires further study as
there exists inadequate research addressing to this issue.
The most remarkable result was a decline in blood
carnitine levels of newborn calves with suspected
septicaemia. Similarly, carnitine was lower in calves
died and recovered of a suspected septicaemia when
compared to healthy calves in this study. This decrease
may be explained in three ways. The first of these may be
inadequate amount of carnitine absorption along with
colostrum as 57% of ill calves developed failure of passive
transfer causing the colostrum to be either insufficient
in quantity or poor in quality (containing low IgG,
immuncomponents including carnitine, etc). It is well
documented that following intestinal absorption colostral
carnitine ester is converted to free carnitine in the liver
of healthy calves [20, 21, 40], but those with suspected
septicaemia, which mainly result in multiple organ failure,
might not had the ability to synthesize enough carnitine as
liver is usually affected [21,41,42]. The second explanation
may be the loss of carnitine due to enteropathy as 44% of
calves developed enteritis in our study. In the condition
of entropaties, constituents of colostrum or milk were
not sufficiently utilised due to disruption of glucose
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and sodium absorption by the immature cells replacing
damaged intestinal cells, which eventually results in
impairments of colostrum absorption [43–46]. This
finding may also indicate the likely role of carnitine
deficiency in the pathogenesis of neonatal calf diseases,
including septicaemia as it is reported to be associated
with growth retardation and increased risk of infection
[26,47,48] The third way may be the role of carnitine in
fight against microorganisms, where carnitine is used up
so the blood level decreases [20,26,41,49,50].
Newborn calves have a very limited hepatic glucose
or energy reserve. Therefore, a poor maternal instinct,
remaining wet, and unfavourable environmental conditions
lead to rapid exhaustion of glucose reserve of the newborn,
which eventually results in hypoglycaemia if calf does not
receive sufficient quality and quantity of colostrum on time
[5,51] as colostrum contains plenty of fats and glucose
[52]. Carnitine has a major role in energy production.
Carnitine deficiency may also have a significant role in
the development of hypoglycaemia, which poses a high
risk of mortality [5,53]. In calves with suspected neonatal
septicaemia, the decrease in glucose level in parallel with
carnitine could be a reflection inadequate colostrum intake
or poor intestinal absorption as high passive colostral
immune deficiency was detected in our study.
Use or discovery of novel biomarkers for clinical
monitorization of diseases can significantly contribute
efficiency to prophylactic and therapeutic strategies
[20]. In the present study, the low blood carnitine levels
detected in calves with suspected septicaemia may suggest
that carnitine could be used as a novel biomarker. A
similar previous study carried out in septic neonates
in human reported that carnitine concentrations were
lower than normal values and the detection of carnitine
concentrations would aid in diagnosis, and therefore,
carnitine supplementation would support treatment [20].
The assessment of the degenerative changes in the
neutrophils showed that the > 2% rate of myelocytes/
metamyelocytes and ≥ 2% rate of toxic neutrophils, both of
which pointed out to septicaemia, had occurred in parallel
with decreased carnitine concentrations. An increased rate
of myelocytes/metamyelocytes and toxic neutrophils in the
peripheral blood can be a direct indicator of septicaemia
and is observed in cases with poor prognosis, where the
bone marrow fails to respond to infections [6,12,54].

In our study, significantly decreased blood carnitine
concentration observed in association with increased
myelocyte/metamyelocyte and toxic neutrophils rates in
the peripheral blood suggests that carnitine is related to
septicaemia or the clinical severity of the disease. However,
further studies are required to support this hypothesis.
The milk carnitine concentration on postpartum day 7
was found significantly higher than the levels detected in
colostrum and postpartum day 1 and day 3. This finding
contradict to that of Sato et al., [21] where high level of
carnitine in colostrum is reported to decline during the
transition to milk. However, Sato et al. [21] also reported
that sudden increases may develop on postpartum day 6
where they measured carnitine on postpartum days of 2, 6,
and 30. On the other hand, colostrum/milk carnitine levels
were measured during the first week of the postpartum
period in the present study.
Overall, this study demonstrated, for the first time,
blood carnitine concentrations in newborn calves, which
were healthy or suspected of having septicaemia, and
the correlation of blood carnitine concentrations with
passive colostral immunity. In calves, immunity is of
utmost significance in protection against infections. The
present study showed that, as an indicator of the active
intestinal absorption of carnitine in newborn calves, the
blood carnitine concentration on postpartum day 2 was
higher than the level measured before colostrum intake.
This study also demonstrated, for the first time, almost
50% decrease in the carnitine concentrations of calves
with suspected septicaemia. Thus, it is suggested that
the measurement of carnitine concentrations could aid
in the diagnosis/prognosis of neonatal calf septicaemia
and that dietary carnitine supplementation or parenteral
administration would be of benefit in the treatment of
these diseases.
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